Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2003
10/16/2003WO2003048164A3 Adenosine a2a receptor antagonists
10/16/2003WO2003041660A3 Solubilized topoisomerase poisons
10/16/2003WO2003039439A3 Deuterated pyrazolopyrimidinones and drugs containing said compounds
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195220 Preparations for oral administration
10/16/2003US20030195218 Treating hyperlipidemic condition, gallstones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195210 An enzyme inhibitors of cyclic guanosine 3',5'-monophophate-metabolizing phosphodiesterases; treating cardiovascular disorders, brian disorders, Alzheimer's disease, urogenital or sexual disorders
10/16/2003US20030195205 PDE9 inhibitors for treating cardiovascular disorders
10/16/2003US20030195196 Pyrrolobenzodiazepines
10/16/2003US20030194646 Optical recording medium and novel azaporphyrin compounds
10/16/2003CA2479810A1 Polymeric acyl derivatives of indoles
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352647A1 Controlled-release sedative hypnotic compositions and method related thereto
10/15/2003EP1351961A1 Substituted indolines as 5-ht receptor ligands
10/15/2003EP1351684A2 Compounds and methods for promoting smoking cessation
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1173181B1 Composition comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
10/15/2003EP0977757B1 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity
10/15/2003EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/15/2003CN1449397A 2,5-dihydro-pyrazolo(3,4-d)pyrimidin-4-ones with an anticonvulsive action and methods for producing the same
10/15/2003CN1449395A Process for preparing azacycloalkanoyl aminothiazoles
10/15/2003CN1449384A Novel ester or amide derivatives
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/14/2003US6632943 Asymmetric reduction of the ketone compound by using metal hydride compound and alcohol compound in the presence of optically active cobalt complex catalyst, purification
10/14/2003US6632942 3S)-piperazic acid is derived from D-glutamic acid through an (R)-2,5-dihydroxyvalerate ester intermediate. After the hydroxy groups are converted to suitable leaving groups, such as mesylates, the ester is treated with a bis-protected
10/14/2003US6632821 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632305 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-substituted precursor, and process, and compounds therefrom
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082871A1 Imidazo fused compounds
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082817A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003WO2003082270A1 Method for treating cognitive disorders
10/09/2003WO2003082208A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002038565A3 7-(r)-amino-triazolopyrimidines, the production thereof and use of the same for combating phytopathogenic fungi
10/09/2003WO2002008228A3 Method for the manufacture of anagrelide
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191150 Process for producing tricyclic fused heterocyclic derivative
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191138 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
10/09/2003US20030191130 [1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists
10/09/2003US20030191122 Antidepressants; Alzheimer's disease; Parkinson's disease; central nervous system disorders
10/09/2003US20030191121 Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparation
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191106 Controlling gramnegative bacteria
10/09/2003US20030191086 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
10/09/2003US20030190540 Photoconductive layer containing azo compound; electrostaticlatent image
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003CA2479644A1 Imidazo fused compounds
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2476923A1 Method for treating cognitive disorders
10/08/2003EP1349962A1 Methods and compositions for detecting polynucleotide duplex damage
10/08/2003EP1349865A2 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
10/08/2003EP1349860A2 Syntheses for preparing 1,4-diketopyrrolo[3,4-c]pyrroles
10/08/2003EP1349859A2 Triazolopyrimidines
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349552A1 Pyrazolo 3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003CN1447811A Medicinal compsns. and its use
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447650A Fungicidal formulation
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630476 For therapy of anxiety, depression, and other psychiatric, neurological disorders, immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress
10/07/2003US6630475 5-amino-pyrazolo-(4, 3-e)-1,2,4-triazolo(1,5-c)pyrimidine adenosine A2a receptor antagonists; use in the treatment of central nervous system diseases, in particular Parkinson's disease
10/07/2003US6630471 Central nervous system disorders
10/07/2003US6630470 G-CSF mimetics
10/07/2003US6630128 Insoluble support
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003WO2003080622A1 Method for the synthesis of porphyrins and calix(4)pyrroles
10/02/2003WO2003080621A1 Process and intermediates to substituted imidazopyrimidines
10/02/2003WO2003080620A1 Inhibitors of nucleoside phosphorylases and nucleosidases
10/02/2003WO2003080619A1 Fused bicyclic pyrimidine derivatives
10/02/2003WO2003080618A1 An improved process for the production of vasicine
10/02/2003WO2003080617A1 Pyrazolopyrimidine derivatives
10/02/2003WO2003080616A1 Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3
10/02/2003WO2003080615A1 Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances
10/02/2003WO2003080614A2 Triazolopyrimidines used as fungicides
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080064A1 Kinase inhibitors
1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 573